Open Access
Instituto superior de ci ncias da sa⁄de
Egas Moniz
- 01 Jan 2014
TL;DR: The regulation of feeding behavior also involves the monoamines dopamine, noradrenalin and serotonin involved in the reward center, a system that values the intake by the feeling of pleasure, and the endocannabinoid system that protects from anxiety and stimulates feeding.
read more
Abstract: 5 Abstract Feeding behavior depends on the balance between food intake and energy expenditure. This regulation occurs in the brain where the hypothalamus plays a key role. The hypothalamus receives adiposity signals by insulin and leptin that gives information about the state of energy reserves. When their levels are low, hypothalamus nuclei send signals through the orexigenic neuropeptides NPY, AgRP, CRH and orexins and ghrelin, a peripheral peptide that stimulate food intake. During ingestion, the first signals received by the brain are the pleasure channeled through the reward system, and the distension of the stomach that is communicated to the brainstem via the vagus nerve. Digestion causes the release of hormones that act as peripheral satiety signals, operating in the brainstem or in the arcuate nucleus (ARC) of the hypothalamus. Examples of such hormones are amylin, pancreatic polypeptide (PP), oxyntomodulin (OXM), cholecystokinin (CCK), glucagon-related peptide (GLP1) and peptide YY (PYY). The regulation of feeding behavior also involves the monoamines dopamine, noradrenalin and serotonin involved in the reward center, a system that values the intake by the feeling of pleasure, and the endocannabinoid system that protects from anxiety and stimulates feeding. Actually, there are few alternative drugs to treat obesity that are effective and safe because the pathways involved in feeding behavior are often easily compensated by other pathways, and are involved in the regulation of other systems.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
•Journal Article
BRIEF COMMUNICATION ARISING: Gut hormone PYY3-36 physiologically inhibits food intake
Rachel L. Batterham,Michael A. Cowley,Caroline J. Small,Herbert Herzog,Mark A Cohen,C. L. Dakin,Alison M. Wren,Audrey E. Brynes,Malcolm J. Low +8 more
TL;DR: The authors showed that post-prandial elevation of PYY3-36 may act through the arcuate nucleus Y2R to inhibit feeding in a gut-hypothalamic pathway.
1.9K
•Journal Article
MDS Clinical Diagnostic Criteria for Parkinson's Disease (S19.001)
Ronald B. Postuma,Daniela Berg +1 more
TL;DR: The International Parkinson and Movement Disorder Society (MDS) Clinical Diagnostic Criteria for Parkinson9s disease as discussed by the authors have been proposed for clinical diagnosis, which are intended for use in clinical research, but may also be used to guide clinical diagnosis.
1.6K
•Journal Article
Association of cocaine- and amphetamine-regulated transcript-immunoreactive elements with thyrotropin-releasing hormone-synthesizing neurons in the hypothalamic paraventricular nucleus and its role in the regulation of the hypothalamic-pituitary-thyroid axis during fasting
Csaba Fekete,Emese Mihály,Lu Guang Luo,Joseph Kelly,Jes Thorn Clausen,Quan Fu Mao,William M. Rand,Larry G. Moss,Michael J. Kuhar,Charles H. Emerson,Ivor M. D. Jackson,Ronald M. Lechan +11 more
TL;DR: In this paper, triple-labeling fluorescent in situ hybridization and immunofluorescence were performed to reveal the morphological relationships between pro-TRH mRNA-containing neurons and CART- and alpha-MSH-immunoreactive (IR) axons.
151
Prandial subcutaneous injections of glucagon-like peptide-1 cause weight loss in obese human subjects
Erik Näslund,Neil A. King,S. Mansten,N. Adner,Jens J. Holst,M. K. Gutniak,Per M. Hellström +6 more
- 01 Jan 2004
TL;DR: In this article, a 5-day infusion of recombinant glucagon-like peptide-1 (7-36)amide (rGLP-1) was shown to cause significant weight loss in type 2 diabetics when administered for 6 weeks as a continuous subcutaneous infusion.
149
References
Inflammation and neuropeptides: the connection in diabetic wound healing
TL;DR: A broad overview of the mediators of the bidirectional connection between the nervous and the immune systems and its role in wound repair is provided, which include neuropeptides and cytokines released from nerve fibres, immune cells and cutaneous cells.
Bond strength of composite to dentin using conventional, one-step, and self-etching adhesive systems.
Serge Bouillaguet,P Gysi,John C. Wataha,B. Ciucchi,Mauro Sergio Dorsa Cattani,Ch Godin,Jean-Marc Meyer +6 more
TL;DR: The conventional adhesive systems produced higher bond strengths to root dentin than most one-step adhesives and one self-etching adhesive; with the exception of one material in each respective system.
252
Orexins (hypocretins) directly interact with neuropeptide Y, POMC and glucose‐responsive neurons to regulate Ca2+ signaling in a reciprocal manner to leptin: orexigenic neuronal pathways in the mediobasal hypothalamus
Shinji Muroya,Shinji Muroya,Hisayuki Funahashi,Akihiro Yamanaka,Daisuke Kohno,Kazuhide Uramura,Kazuhide Uramura,Tadahiro Nambu,Megumi Shibahara,Motoki Kuramochi,Morikuni Takigawa,Masashi Yanagisawa,Takeshi Sakurai,Seiji Shioda,Toshihiko Yada +14 more
TL;DR: It is demonstrated that orexins directly regulate NPY, POMC and glucose‐responsive neurons in the ARC and VMH, in a manner reciprocal to leptin, as well as neural pathways and intracellular signaling mechanisms that may play key roles in the orexigenic action of orexlins.
251
Overview and pathogenesis of celiac disease
TL;DR: The proportion of individuals presenting with more dramatic symptoms of diarrhea, severe weight loss, and malnutrition is decreasing when compared with those presenting with mild or minimal symptoms or asymptomatic individuals in which disease is discovered only when investigating nongastrointestinal symptoms.
248
Selenium, selenoproteins and neurodegenerative diseases
Bárbara Rita Cardoso,Bárbara Rita Cardoso,Blaine R. Roberts,Ashley I. Bush,Dominic J. Hare,Dominic J. Hare,Dominic J. Hare +6 more
TL;DR: This review discusses selenium metabolism in detail, specifically with regard to the role it plays within the central nervous system, and examines the most current literature investigating how seenocysteine may be involved in chronic diseases of thecentral nervous system.